BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2502422)

  • 1. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
    Takemura Y; Koide Y; Kawabata M; Kitajima S; Ohba C; Suzuki H; Sekiguchi S
    Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
    Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
    Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells.
    Leeuwenberg JF; Van Damme J; Meager T; Jeunhomme TM; Buurman WA
    Eur J Immunol; 1988 Sep; 18(9):1469-72. PubMed ID: 3139431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
    Stemme S; Fager G; Hansson GK
    Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression.
    Pessara U; Momburg F; Koch N
    Eur J Immunol; 1988 Nov; 18(11):1719-26. PubMed ID: 3144453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha.
    Scotlandi K; Baldini N; Campanacci M; Lollini PL; Picci P; Serra M
    Anticancer Res; 1992; 12(3):767-72. PubMed ID: 1622136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of verapamil on the class I major histocompatibility complex antigen expression in K562 chronic myelogenous leukemia cells treated with recombinant human interferon-gamma.
    Takemura Y; Koide Y; Miyachi H; Shibata T; Sekiguchi S
    Cancer Lett; 1992 Aug; 65(2):99-106. PubMed ID: 1511424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
    Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
    Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
    Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
    J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells.
    Pan LY; Mendel DB; Zurlo J; Guyre PM
    J Immunol; 1990 Jul; 145(1):267-75. PubMed ID: 2141616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
    Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
    Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids.
    Rhodes J; Ivanyi J; Cozens P
    Eur J Immunol; 1986 Apr; 16(4):370-5. PubMed ID: 2422040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
    Ruggiero V; Tavernier J; Fiers W; Baglioni C
    J Immunol; 1986 Apr; 136(7):2445-50. PubMed ID: 3005411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines.
    Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H
    Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS; Banez M; Okun E; Morton DL; Irie RF
    Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
    Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
    J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.